Literature DB >> 23468277

[Geriatric multimorbidity in claims data: part 3: prevalence and predictive power of geriatric conditions in an age-specific systematic sample].

M Meinck1, N Lübke.   

Abstract

BACKGROUND: In various contexts, the identification of insurants with geriatric conditions (GC) can offer new approaches for specific medical services. GC can be determined from diagnoses data of insurants retrieved from different care sectors, and supplemented with other relevant claims data, e.g., long-term care levels and pharmaceutical data.
METHODS: Part 3 of this study is based on a systematic sample of 957,447 AOK insurants (age ≥ 60 years). Prevalence of 15 GC was investigated using anonymous claims data of diagnoses from physicians in the ambulant care setting and diagnoses from hospital settings in 2008. In addition the potential relationships of GC with mortality, nursing home admission, need for long-term care and hospital utilization in the following year were examined. All results were standardized by gender and age based on the general population aged ≥ 60 years in Germany.
RESULTS: Pain and impairment of vision or hearing was the most common GC (> 25%) followed by high risk of complications, fall risk/dizziness, and cognitive deficit (8-14%). Delayed convalescence, frailty, medication problems, immobility and malnutrition occurred in < 1% of the insurants. Almost all GC occurred more often with increasing age. Only 37% insurants in the sample showed no GC, while for 31% exactly one, for 17% two, and for 15% three or more GC were observed. With the exception of pain and impairment of vision or hearing all of the GC had a significant positive association with mortality, nursing home admission, increasing need of care, and hospital utilization in the following year.
CONCLUSIONS: The applied operational approach proved to be generally practicable and successful with few adaptations. The GC pain and impairment of vision or hearing, however, do not contribute sufficiently to the identification of geriatric multimorbidity based on claims data. These GC should be therefore disregarded from such identification processes. To enhance the reliability of an identified geriatric multimorbidity, the requirements on the specificity and number of individual GC (two, three, or more) can be adapted.

Entities:  

Mesh:

Year:  2013        PMID: 23468277     DOI: 10.1007/s00391-012-0462-8

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  9 in total

Review 1.  Causes and consequences of comorbidity: a review.

Authors:  R Gijsen; N Hoeymans; F G Schellevis; D Ruwaard; W A Satariano; G A van den Bos
Journal:  J Clin Epidemiol       Date:  2001-07       Impact factor: 6.437

2.  [The research associations "Health in old age": current results on multimorbidity in old age from an interdisciplinary perspective].

Authors:  A Kuhlmey; W von Renteln-Kruse
Journal:  Z Gerontol Geriatr       Date:  2011-12       Impact factor: 1.281

3.  [Geriatric multimorbidity in claims data - part 2 : diagnoses of hospitals and diagnoses from physicians in the ambulatory setting].

Authors:  M Meinck; N Lübke; F Ernst
Journal:  Z Gerontol Geriatr       Date:  2012-10       Impact factor: 1.281

4.  [Geriatric multimorbidity in claims data - part 1. Analysis of hospital data and long-term care insurance data].

Authors:  N Lübke; M Meinck
Journal:  Z Gerontol Geriatr       Date:  2012-08       Impact factor: 1.281

5.  Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases.

Authors:  M van den Akker; F Buntinx; J F Metsemakers; S Roos; J A Knottnerus
Journal:  J Clin Epidemiol       Date:  1998-05       Impact factor: 6.437

6.  Which chronic diseases and disease combinations are specific to multimorbidity in the elderly? Results of a claims data based cross-sectional study in Germany.

Authors:  Hendrik van den Bussche; Daniela Koller; Tina Kolonko; Heike Hansen; Karl Wegscheider; Gerd Glaeske; Eike-Christin von Leitner; Ingmar Schäfer; Gerhard Schön
Journal:  BMC Public Health       Date:  2011-02-14       Impact factor: 3.295

7.  Prevalence of chronic diseases and multimorbidity among the elderly population in Sweden.

Authors:  Alessandra Marengoni; Bengt Winblad; Anita Karp; Laura Fratiglioni
Journal:  Am J Public Health       Date:  2008-05-29       Impact factor: 9.308

8.  Prevalence estimates of multimorbidity: a comparative study of two sources.

Authors:  Martin Fortin; Catherine Hudon; Jeannie Haggerty; Marjan van den Akker; José Almirall
Journal:  BMC Health Serv Res       Date:  2010-05-06       Impact factor: 2.655

9.  Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia.

Authors:  Falk Hoffmann; Hendrik van den Bussche; Birgitt Wiese; Gerhard Schön; Daniela Koller; Marion Eisele; Gerd Glaeske; Martin Scherer; Hanna Kaduszkiewicz
Journal:  BMC Psychiatry       Date:  2011-12-06       Impact factor: 3.630

  9 in total
  4 in total

1.  [Patients with pain in outpatient care. A nationwide cross-sectional survey with path model].

Authors:  M Leiske; N A Lahmann; G Lindena; R Centmayer; R Suhr
Journal:  Schmerz       Date:  2015-08       Impact factor: 1.107

Review 2.  [Geriatrics - an interdisciplinary challenge].

Authors:  Roland Nau; Marija Djukic; Manfred Wappler
Journal:  Nervenarzt       Date:  2016-06       Impact factor: 1.214

3.  [Treatment by panel physicians of patients in protective institutions and homes : Analysis based on secondary data].

Authors:  Diana Kurch-Bek; Leonie Sundmacher; Christian Gallowitz; Bernhard Tenckhoff
Journal:  Z Gerontol Geriatr       Date:  2016-11-04       Impact factor: 1.281

4.  How does age affect the care dependency risk one year after stroke? A study based on claims data from a German health insurance fund.

Authors:  Susanne Schnitzer; Olaf von dem Knesebeck; Martin Kohler; Dirk Peschke; Adelheid Kuhlmey; Liane Schenk
Journal:  BMC Geriatr       Date:  2015-10-23       Impact factor: 3.921

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.